- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02901847
To Evaluate the Introduction of a Public Health Approach to Peripheral Arterial Disease (PAD) Using National Centre for Sport and Exercise Medicine Facilities. (PodPAD)
February 12, 2019 updated by: Sheffield Teaching Hospitals NHS Foundation Trust
The aim of the project is to investigate the clinical and patient centred outcomes of people with Peripheral Arterial Disease (PAD) attending a podiatry led integrated care pathway, utilising advice on diet, activity and smoking cessation.
The podiatry clinic will be delivered from the Move More centre (NCSEM) and participants will be encouraged to access these facilities as part of their activity programme which will be agreed with the physical activity team.
Primary and secondary outcomes will be clinical - claudication pain, distance walked at 3 and 6 months, blood pressure and lipid monitoring, weight management, reduced BMI, and the success of any smoking cessation.
Quality of life and patient satisfaction with the programme will also be assessed.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
21
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Sheffield, United Kingdom, S10 2JF
- Sheffield Teaching Hospitals NHS Foundation Trust
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- adult patient between the ages of 50-90 years,
- Patient attending for podiatry treatment
- diagnosis of PAD or is showing signs of symptoms of PAD
- wishes to take part in the study.
Exclusion Criteria:
- Anyone unable to give informed consent due to lack of mental capacity.
- Anyone who would be unable to participate in increased activity due to other co-morbidities
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Intervention
PAD tailored care
|
PAD tailored care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Distance walked before onset of intermittent claudication
Time Frame: 6 months
|
Distance walked before onset of intermittent claudication
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2016
Primary Completion (Actual)
November 1, 2017
Study Completion (Actual)
November 1, 2017
Study Registration Dates
First Submitted
September 12, 2016
First Submitted That Met QC Criteria
September 12, 2016
First Posted (Estimate)
September 15, 2016
Study Record Updates
Last Update Posted (Actual)
February 15, 2019
Last Update Submitted That Met QC Criteria
February 12, 2019
Last Verified
February 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STH19410
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Peripheral Arterial Disease
-
University of NebraskaNot yet recruitingPeripheral Arterial Disease | Peripheral Vascular Diseases | Peripheral Arterial Occlusive Disease | Peripheral Artery DiseaseUnited States
-
CID S.p.A.Meditrial Europe Ltd.Not yet recruitingPeripheral Arterial Occlusive Disease | Peripheral Artery DiseaseItaly
-
Marissa JarosinskiRecruitingPeripheral Arterial Occlusive Disease | Peripheral Vascular Disease | Peripheral Artery Disease | Clopidogrel, Poor Metabolism of | Artery DiseaseUnited States
-
Stanford UniversityTerminatedPAD - Peripheral Arterial Disease | PVD- Peripheral Vascular DiseaseUnited States
-
Vascuros Medical Pte LtdNovella ClinicalUnknownPeripheral Arterial Occlusive Disease | Peripheral Vascular Disease | Peripheral Artery DiseaseSingapore, Belgium, Germany
-
Western Vascular Institute, IrelandRecruitingPeripheral Arterial Occlusive DiseaseIreland
-
Jena University HospitalAngioDroid s.r.l., Bologna (Italy)CompletedPeripheral Arterial Occlusive DiseaseGermany
-
Seoul National University HospitalAstellas Pharma Korea, Inc.CompletedPeripheral Arterial Occlusive DiseaseKorea, Republic of
-
Heidelberg UniversityTerminatedPeripheral Arterial Occlusive DiseaseGermany
-
Johann Wolfgang Goethe University HospitalSuspendedPeripheral Arterial Occlusive DiseaseGermany
Clinical Trials on PAD tailored care
-
National Taiwan University Hospital Hsin-Chu BranchUnknownSepsis | Peripheral Artery Disease | Diagnosis | Peripheral Artery OcclusionTaiwan
-
University of AarhusDanish Cancer SocietyCompletedCancer | Geriatric AssessmentDenmark
-
National Cancer Center, KoreaSamsung Medical Center; Seoul National University Hospital; Korea University...UnknownCancer-related FatigueKorea, Republic of
-
Rutgers, The State University of New JerseyNational Institute on Aging (NIA)Not yet recruitingAlzheimer's Disease and Related Dementias
-
Milton S. Hershey Medical CenterNational Institute of Nursing Research (NINR); ANFCompletedSleep Apnea, Obstructive | Patient ComplianceUnited States
-
Vrije Universiteit BrusselKU Leuven; Agentschap voor Innovatie door Wetenschap en Technologie; Maastricht... and other collaboratorsCompleted
-
Odense University HospitalUniversity of Southern DenmarkCompletedStroke | Transient Ischemic AttackDenmark
-
University Hospitals of North Midlands NHS TrustRecruitingAsthma | Asthma in ChildrenUnited Kingdom
-
Chinese University of Hong KongThe Hong Kong Polytechnic UniversityCompletedKnee Arthropathy | Hypertrophic Scar | Hip ArthropathyHong Kong
-
State University of New York - Upstate Medical...CompletedIschemic Stroke | TIAUnited States